Revelation Biosciences, Inc. (REVBW) bonds
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Revelation Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Revelation Biosciences's 10-K/A for the period ended Feb 28, 2021
| Issue | Coupon |
|---|---|
| Convertible Debt Convertible | 10.00% |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K/A.